Lexicon Pharmaceutcl (LXRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2008 | 03-2008 | 12-2007 | 09-2007 | 06-2007 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 109,649 | 59,457 | 22,938 | 50,721 | 22,587 |
| Marketable Securities | 34,308 | 110,051 | 235,837 | 223,194 | 72,645 |
| Receivables | 672 | 1,244 | 1,763 | 1,747 | 1,357 |
| TOTAL | $152,950 | $174,375 | $264,650 | $279,402 | $100,281 |
| Non-Current Assets | |||||
| PPE Net | 68,104 | 69,650 | 70,829 | 72,350 | 74,214 |
| Investments And Advances | 56,560 | 59,288 | 0 | 0 | 0 |
| Intangibles | 25,798 | 25,798 | 25,798 | 25,798 | 25,798 |
| Other Non-Current Assets | 6,894 | 7,462 | 8,019 | 642 | 669 |
| TOTAL | $157,356 | $162,198 | $104,646 | $98,790 | $100,681 |
| Total Assets | $310,306 | $336,573 | $369,296 | $378,192 | $200,962 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 924 | 905 | 880 | 861 | 844 |
| Accounts payable and accrued liabilities | 7,920 | 4,252 | 7,344 | 4,913 | 4,701 |
| Accrued Expenses | 8,489 | 9,393 | 9,093 | 8,593 | 7,556 |
| TOTAL | $27,656 | $27,691 | $35,347 | $37,345 | $39,495 |
| Non-Current Liabilities | |||||
| Long Term Debt | 30,018 | 30,251 | 30,493 | 30,723 | 30,942 |
| Deferred Revenues | 10,323 | 13,141 | 18,030 | 22,978 | 26,394 |
| Other Non-Current Liabilities | 19,963 | 26,111 | 31,030 | 26,734 | 30,657 |
| TOTAL | $64,193 | $71,081 | $77,649 | $75,458 | $81,532 |
| Total Liabilities | $91,849 | $98,772 | $112,996 | $112,803 | $121,027 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 19,548 | 19,548 | 19,548 | 19,548 | 12,284 |
| Common Shares | 137 | 137 | 137 | 137 | 86 |
| Retained earnings | -448,519 | -428,485 | -410,535 | -398,358 | -384,247 |
| Other shareholders' equity | -3,225 | -2,332 | -4 | -162 | -9 |
| TOTAL | $218,457 | $237,801 | $256,300 | $265,389 | $79,935 |
| Total Liabilities And Equity | $310,306 | $336,573 | $369,296 | $378,192 | $200,962 |